Oragenics Raises CEO Salary, Awards Stock Options to Executives and Directors

Reuters12-16
Oragenics Raises CEO Salary, Awards Stock Options to Executives and Directors

Oragenics Inc. has announced changes to its executive and director compensation. Effective January 1, 2026, Chief Executive Officer Janet Huffman's annual base salary will increase by 5% from $325,000 to $341,250. She has also been awarded a bonus of $110,500 for her performance. Additionally, Ms. Huffman received a stock option grant to purchase 250,000 shares at $0.93 per share, vesting in equal installments over three years. Non-Employee Directors were each granted options to purchase 125,000 shares at $0.93 per share, with immediate vesting. Natasha Giordano, appointed to the Board in September 2025, received an onboarding stock option valued at $30,000, which also vested immediately.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oragenics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-027745), on December 15, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment